Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:e240–327.

Google Scholar 

GBD. Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.

Article  Google Scholar 

World Health Organization. Noncommunicable diseases country profiles 2018. 2018. https://apps.who.int/iris/handle/10665/274512.

Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19.

Article  CAS  Google Scholar 

Stevens G, Mascarenhas M, Mathers C. Global health risks: progress and challenges. Bull World Health Organ. 2009;87:646.

Article  Google Scholar 

Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The Progression From Hypertension to Congestive Heart Failure. JAMA. 1996;275:1557–62.

Article  CAS  Google Scholar 

Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363–9.

Article  Google Scholar 

Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–72.

Article  Google Scholar 

Whelton PK, He J. Blood pressure reduction. In: Hennekens CH, Buring JE, Manson JE, Ridker PM, editors. Clinical trials in cardiovascular disease. A companion to Braunwald’s heart disease. Philadelphia: WB Saunders; 1999:341–359.

Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356:1955–64.

Article  CAS  Google Scholar 

Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69–75.

Article  CAS  Google Scholar 

Cuspidi C, Valerio C, Negri F, Sala C, Masaidi M, Giudici V, et al. Prevalence and correlates of multiple organ damage in referred treated hypertensives: data from the ETODH study. J Hum Hypertens. 2008;22:801–3.

Article  CAS  Google Scholar 

Whitworth JA. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–92. 2003

Article  Google Scholar 

Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305–13.

Article  CAS  Google Scholar 

Hill MN, Bone LR, Kim MT, Miller DJ, Dennison CR, Levine DM. Barriers to hypertension care and control in young urban black men. Am J Hypertens. 1999;12:951–8.

Article  CAS  Google Scholar 

Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB, et al. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. J Hypertens. 2011;29:1641–8.

Article  CAS  Google Scholar 

Ham OK, Yang SJ. Lifestyle factors associated with blood pressure control among those taking antihypertensive medication. Asia Pac J Public Health. 2011;23:485–95.

Article  Google Scholar 

Gaggin HK, Januzzi JL. Cardiac biomarkers and heart failure. American College of Cardiology; 2015. https://www.acc.org/%2Flatest-in-cardiology%2Farticles%2F2015%2F02%2F09%2F13%2F00%2Fcardiac-biomarkers-and-heart-failure.

Flack JM, Calhoun D, Schiffrin EL. The new ACC/AHA hypertension guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults. Am J Hypertens. 2017;31:133–5.

Article  Google Scholar 

Chapter 2. Measurement and clinical evaluation of blood pressure. Hypertens Res. 2009;32:11–23.

Article  Google Scholar 

Elhenawy YI, Abdelmageed RI, Zaafar DK, Abdelaziz AW. Adherence to insulin therapy among children with type 1 diabetes: reliability and validity of the Arabic version of the 4-item Morisky Medication Adherence Scale. Patient Prefer Adherence. 2022;16:1415–21.

Article  Google Scholar 

Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.

Article  CAS  Google Scholar 

Lee HSC, Lee HSC, Lee HSC, Lee HSC. Abstract P157: challenging blood pressure control in heart failure patients and related factors. Hypertension. 2020;76:AP157–AP.

Article  Google Scholar 

Okaka EI, Ojeh-Oziegbe OE, Unuigbe EI. Factors associated with blood pressure control in predialysis chronic kidney disease patients: Short-term experience from a single center in Southern Nigeria. Niger J Clin Pr. 2017;20:537–41.

Article  CAS  Google Scholar 

Mbwete GW, Kilonzo KG, Shao ER, Chamba NG. Suboptimal blood pressure control, associated factors, and choice of antihypertensive drugs among type 2 diabetic patients at KCMC, Tanzania. J Diabetes Res. 2020;2020:4376251.

Article  Google Scholar 

Xu D, Chen W, Li X, Zhang Y, Li X, Lei H, et al. Factors associated with blood pressure control in hypertensive patients with coronary heart disease: evidence from the Chinese cholesterol education program. PLOS One. 2013;8:e63135.

Article  CAS  Google Scholar 

Lip GY, Skjøth F, Overvad K, Rasmussen LH, Larsen TB. Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. Clin Res Cardiol. 2015;104:1088–96.

Article  Google Scholar 

Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, et al. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart. 2009;95:56–62.

Article  CAS  Google Scholar 

Schmid FA, Schlager O, Keller P, Seifert B, Huang R, Fröhlich GM, et al. Prognostic value of long‐term blood pressure changes in patients with chronic heart failure. Eur J Heart Fail. 2017;19:837–42.

Article  Google Scholar 

Hoffmann TC, Lewis J, Maher CG. Shared decision making should be an integral part of physiotherapy practice. Physiotherapy. 2020;107:43–9.

Article  Google Scholar 

DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9.

Article  Google Scholar 

Hamarneh D, Alkhatib N, Denhaerynck K, Vancayzeele S, Brié H, MacDonald K, et al. Gender-stratified hierarchical modeling of patient and physician determinants of antihypertensive treatment outcomes: pooled analysis of seven prospective real-world studies with 17,044 patients. Curr Med Res Opin. 2021;37:367–75.

Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48:562–70.

Article  Google Scholar 

Murphy AC, Proeschal A, Brightling CE, Wardlaw AJ, Pavord I, Bradding P, et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax. 2012;67:751–3.

Article  Google Scholar 

Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, et al. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Car Fail. 2011;17:664–9.

Article  Google Scholar 

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11:532–46.

Article  Google Scholar 

Haley WE, Gilbert ON, Riley RF, Newman JC, Roumie CL, Whittle J, et al. The association between self- reported medication adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens. 2016;10:857–64.

Article  Google Scholar 

Centers for Disease Control and Prevention (CDC). Vital signs: awareness and treatment of uncontrolled hypertension among adults-United States, 2003-2010. MMWR Morb Mortal Wkly Rep. 2012;61:703–9.

Google Scholar 

About digoxin. 2020. https://www.nhs.uk/medicines/digoxin/about-digoxin/.

Kirch C, Grossmann M, Fischer S, Neumeister V, Kirch W. Effect of digoxin on circadian blood pressure values in patients with congestive heart failure. Eur J Clin Invest. 2000;30:285–9.

Article  CAS  Google Scholar 

Grossmann M, Jamieson M, Kirch W. Effects of digoxin and digitoxin on circadian blood pressure profile in healthy volunteers. Eur J Clin Invest. 1998;28:701–6.

Article  CAS  Google Scholar 

How do aldosterone antagonists work? 2022. https://my.clevelandclinic.org/health/treatments/22917-aldosterone-antagonists.

List of Aldosterone receptor antagonists. 2022. https://www.drugs.com/drug-class/aldosterone-receptor-antagonists.html.

Liu G, Zheng XX, Xu YL, Lu J, Hui RT, Huang XH. Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis. J Hum Hypertens. 2015;29:159–66.

Article  CAS  Google Scholar 

Marcy TR, Ripley TL. Aldosterone antagonists in the treatment of heart failure. Am J Health Syst Pharm. 2006;63:49–58.

Article  CAS  Google Scholar